Back
Medifast 10K Form
Sell
25
MED
Medifast
Last Price:
$13.13
Seasonality Move:
17.24%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-04-29 | 10Q | MED/Medifast Quarterly |
| 2023-11-06 | 10Q | MED/Medifast Quarterly |
| 2023-08-07 | 10Q | MED/Medifast Quarterly |
| 2023-05-01 | 10Q | MED/Medifast Quarterly |
| 2022-11-03 | 10Q | MED/Medifast Quarterly |
| 2022-08-03 | 10Q | MED/Medifast Quarterly |
Receive MED News And Ratings
See the #1 stock for the next 7 days that we like better than MED
MED Financial Statistics
Sales & Book Value
| Annual Sales: | $602.5M |
|---|---|
| Cash Flow: | $-7.2M |
| Price / Cash Flow: | 8.46 |
| Annual Sales: | $19.21 |
| Price / Book: | 0.68 |
Profitability
| EPS (TTM): | 0.18000 |
|---|---|
| Net Income (TTM): | $2.1M |
| Gross Margin: | $444.6M |
| Return on Equity: | 1.01% |
| Return on Assets: | 0.71% |
Medifast Earnings Forecast
Key Medifast Financial Ratios
-
The Gross Profit Margin over the past 29 years for MED is 73.80%.
-
The Selling, General & Administrative Expenses for MED have been equal to 73.32% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 0.49% of Operating Income.
-
The Net Earning history of MED is 0.35% of Total Revenues.
-
Per Share Earnings over the last 29 years have been positive in 15 years.
Medifast Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Personal Care Products |
| Sector: | Consumer Staples |
| Current Symbol: | MED |
| CUSIP: | 58470H |
| Website: | medifastinc.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 3.34 |
| Quick Ratio: | 2.53 |
Price-to-Earnings
| Trailing P/E Ratio: | 69.16 |
|---|---|
| Forward P/E Ratio: | 32.26 |